Home › Drugs › Sodium valproate (Depakine)
Sodium valproate (Depakine)
فالبروات الصوديوم (ديباكين) · Broad-spectrum antiepileptic · Pain & nervous system
Acts on: Cerebrum
Main adverse effects on: Liver Pancreas Pelvis
Mechanism of action
Increases GABA and blocks sodium and calcium channels, reducing seizures.
Uses
Generalised epilepsies, bipolar disorder, migraine prevention.
Side effects
- Severe birth defects and developmental problems in the fetus
- Liver failure (especially under 2 years)
- Pancreatitis
- Weight gain, hair loss, tremor
🚫 Contraindications
- Pregnancy (for epilepsy unless no alternative; never for migraine or bipolar)
- Women of childbearing potential without effective contraception
- Active or familial liver disease
- Mitochondrial disease (POLG)
- Porphyria
🤰 Pregnancy
Contraindicated Contraindicated: among the most teratogenic drugs (about 1 in 10 malformed) and neurodevelopmental problems (up to 4 in 10).
🍼 Breastfeeding
Caution Usually acceptable; observe the infant.
Clinical points & patient counselling
Not for girls or women of childbearing potential unless on a pregnancy-prevention programme and alternatives failed. Monitor liver and platelets.
Tests to monitor
⚕️ Educational content; it does not replace a doctor, pharmacist or official references. Values and doses vary by lab, country and leaflet.